about
Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritisTreatment for lupus nephritisSystemic lupus erythematosusCurrent and emerging treatment options in the management of lupusNanosized contrast agents to noninvasively detect kidney inflammation by magnetic resonance imagingGlomerular disease: perspectives on maintenance therapy in lupus nephritisA treatment algorithm for children with lupus nephritis to prevent developing renal failureBench-to-bedside review: Pulmonary–renal syndromes – an update for the intensivistAn Update on Treatment and Management of Pediatric Systemic Lupus ErythematosusPediatric lupus nephritis: Management updateIn vivo, multimodal imaging of B cell distribution and response to antibody immunotherapy in miceRisk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis.Novel therapeutic approaches to lupus glomerulonephritis: translating animal models to clinical practice.Retrospective analysis of patients with lupus nephritis: data from a large clinical immunological center in Hungary.Management of therapy-resistant systemic lupus erythematosus with rituximab: report of a case and review of the literature.Successful treatment of refractory thrombocytopenia with mycophenolate mofetil in a patient with systemic lupus erythematosus.Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review.Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.Acute kidney injury in Chinese patients with lupus nephritis: a large cohort study from a single center.The spectrum of renal thrombotic microangiopathy in lupus nephritis.A novel immunomodulatory treatment involving mycophenolate mofetil and corticosteroids for pediatric autoimmune cytopenias.Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults.Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosisMycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.Mannose receptor interacts with Fc receptors and is critical for the development of crescentic glomerulonephritis in mice.Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia.Current status of lupus nephritis.Recent clinical trials in lupus nephritis.Lupus nephritis: lessons from murine modelsCyclophosphamide and lupus nephritis: when, how, for how long?Is newer safer? Adverse events associated with first-line therapies for ANCA-associated vasculitis and lupus nephritis.Population pharmacokinetics of mycophenolic acid and metabolites in patients with glomerulonephritis.BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus.Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.Belimumab for the treatment of systemic lupus erythematosus.Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis.Value of repeat biopsy in lupus nephritis flaresEfficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis.Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study.
P2860
Q21195423-FE6AF512-345E-4720-A827-CC5105D5105BQ24202572-6E5EE9D0-6098-43DC-ABCE-670D8289D93EQ24543555-BD4D013A-6DD1-45CD-8A97-8016789F8A6FQ26741266-18C920F4-89E4-4FC2-BCC3-FC245C4DE08DQ26864381-D12BA71A-4A86-4AFD-AC03-23730E48433CQ26866290-6BDDC4E7-1F93-4F81-B30A-C1276CBB1DBAQ27026880-ECBD4F7B-11C0-4DB8-B660-86ECE07BCBD4Q27485164-6915A176-F017-40E0-B85E-24D1C19C7101Q28074348-B2C6AC7A-CA0D-4E60-AAAF-B81A671167B0Q28660110-78588E8A-DCE0-435F-B74D-2C7DDA9B6812Q28752150-241F3884-347E-4F45-B177-4296EA031B32Q30245390-F1543DF1-5E4E-4C5F-9EB7-90616D9ECC43Q30427986-4AF41F67-2B10-44A1-B9F1-CEB9E948F1B9Q31060896-9422AE62-D496-458D-A10F-470A275BAF54Q33367691-F49445FD-7AE6-4D8C-AF88-62EE3D2179F0Q33368914-4046365C-A89B-402D-9F79-643D58C908F1Q33377162-025B63CB-F900-40FE-9A9B-85E497DC671EQ33387348-78771FE9-6CB9-48FA-ADD5-00454C7BD0CFQ33397614-C70D0A9B-36AC-4375-BA1B-DC26E2672D4EQ33405303-2B6B8BD9-94B5-49A9-BE5A-9304829E239DQ33435295-E990DE68-9D69-4D43-B3CC-C1CFDA4F01ADQ33560549-EA813945-7F39-4536-9B76-2D1332656E96Q33602730-1A7B0839-0AD1-49B9-8994-C812DE81E7AFQ33684065-5D5E4667-DA17-4973-873B-0092C4D296D0Q33806541-394B62A9-804A-4490-B758-C34D249AAA0EQ33815783-C3CF47D3-C6E4-4D41-9AA2-652E5992D165Q33820120-574EE986-F2AF-4C35-8F22-91981DB810CFQ33882751-3D2A8A4B-4CB7-4124-AE1F-EFCD3A3F93F2Q33924437-1BC1A443-3014-4AD4-8C38-103425CAEAE4Q33998360-F786146D-87BF-4022-BC97-074D47B4AC6BQ34095231-6856FD6B-AFAA-46CF-87A9-9B6F1D13C878Q34124711-C803B529-C7CE-4051-AC2A-11DDF9B84CCCQ34152549-D39081F4-D9D7-490C-A1C9-F32391D9A84FQ34245983-B9726F0D-2B09-4705-A801-E209C6D8EF70Q34409787-99F589FC-6AA1-47C3-B641-4F80A14E96BCQ34455827-4A5023BE-90E1-4889-A6F8-01BE2E5C8201Q34462600-5668878D-8D8F-46AA-8C70-A1CBE5D079C4Q34478821-F6E7E008-90B1-4E8B-B2FF-7E80310A2514Q34490782-51752DD6-9DF4-440D-9CA5-221AA474C9EBQ34613945-3CD9CA9C-809A-496A-A6FA-11ED900362F1
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Sequential therapies for proliferative lupus nephritis.
@en
type
label
Sequential therapies for proliferative lupus nephritis.
@en
prefLabel
Sequential therapies for proliferative lupus nephritis.
@en
P2093
P356
P1476
Sequential therapies for proliferative lupus nephritis.
@en
P2093
Baudouin Leclercq
David Roth
Elaine Tozman
Gabriel Contreras
Oliver Lenz
Patricia O'Nan
Victoriano Pardo
P304
P356
10.1056/NEJMOA031855
P407
P577
2004-03-01T00:00:00Z